Latest News In AI Chips - Cerebras CS-4 Revolutionizes AI Inference Speed and Efficiency

Cerebras Systems has introduced the CS-4, a significant advancement in AI chips, claiming it to be the fastest AI accelerator available today. Built on the new Wafer Scale Engine 3 Turbo, the CS-4 offers up to 30 times more speed and 10 times more throughput per watt compared to GPU-based solutions, significantly enhancing data center efficiency. This new development sets a benchmark for AI inference speed and enables support for models with over 50 trillion parameters. The CS-4, part of a modular platform architecture, brings advancements in deployability and reliability, reshaping expectations for AI performance at scale.

• Cerebras Systems (NasdaqGS:CBRS) last closed at $220.01 down 12.7%.

In other trading, GRINM Semiconductor Materials (SHSE:688432) was trading firmly up 13.4% and closing at CN¥49.48. Meanwhile, Shanghai Iluvatar CoreX Semiconductor (SEHK:9903) trailed, down 13.4% to close at HK$368.00.

Micron Technology's shift to high-margin products amidst booming AI demand offers compelling growth potential. Discover more about Micron's strategic moves in our detailed narrative.

Be sure to check out our earlier Market Insights article, "Earnings Season vs. AI," where we analyzed the growing impact of AI investment on companies like Nvidia and the transforming software sector; don't miss this crucial insight before the window closes.

Best AI Chip Stocks

• NVIDIA (NasdaqGS:NVDA) settled at $219.74 down 2.3%. Two days ago, NVIDIA announced a partnership with SB Energy for AI compute infrastructure at PORTS-Pike in Ohio, securing significant capacity for future AI development.
• Broadcom (NasdaqGS:AVGO) settled at $380.00 down 3.2%.
• Micron Technology (NasdaqGS:MU) settled at $940.76 down 7.0%.

Turning Ideas Into Actions

• Click through to start exploring the rest of the 123 AI Chip Stocks including IonQ, Intel and Kioxia Holdings now.
• Seeking Other Investments? The end of cancer? These 33 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Sources:

• Simply Wall St
• "Cerebras Unveils CS-4: Up to 30 Times Faster than GPU-based Solutions" from Cerebras Systems Inc. on GlobeNewswire (published 19 August 2026)

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com